ALXO – alx oncology holdings inc. (US:NASDAQ)
Stock Stats
News
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules [Yahoo! Finance]
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
Form 4 ALX ONCOLOGY HOLDINGS For: Apr 16 Filed by: Klencke Barbara
Form 4 ALX ONCOLOGY HOLDINGS For: Apr 16 Filed by: Knight Jeff E.
Form 3 ALX ONCOLOGY HOLDINGS For: Apr 13 Filed by: Knight Jeff E.
Form 8-K ALX ONCOLOGY HOLDINGS For: Apr 13
Form 4 ALX ONCOLOGY HOLDINGS For: Mar 19 Filed by: Lettmann Jason
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.